Home LiteratureArticle Details
PMID: 17591968 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.

The American journal of pathology ·Vol. 171 ·No. 1 ·2007-07-00 ·Pages 227-40

Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee VM, Mackenzie IR

Abstract

TAR DNA-binding protein 43 (TDP-43) is a major pathological protein of sporadic and familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions (FTLD-U) with or without motor neuron disease (MND). Thus, TDP-43 defines a novel class of neurodegenerative diseases called TDP-43 proteinopathies. We performed ubiquitin and TDP-43 immunohistochemistry on 193 cases of familial and sporadic FTLD with or without MND. On selected cases, immunoelectron microscopy and biochemistry were performed. Clinically defined frontotemporal dementias (FTDs) included four groups: 1) familial FTD with mutations in progranulin (n = 36), valosin-containing protein (n = 5), charged multivesicular body protein 2B (n = 4), and linked to chromosome 9p (n = 7); 2) familial cases of FTD with unknown gene association (n = 29); 3) sporadic FTD (n = 72); and 4) familial and sporadic FTD with MND (n = 40). Our studies confirm that the spectrum of TDP-43 proteinopathies includes most cases of sporadic and familial FTLD-U with and without MND and expand this disease spectrum to include reported families with FTD linked to chromosome 9p but not FTD with charged multivesicular body protein 2B mutations. Thus, despite significant clinical, genetic, and neuropathological heterogeneity of FTLD-U, TDP-43 is a common pathological substrate underlying a large subset of these disorders, thereby implicating TDP-43 in novel and unifying mechanisms of FTLD pathogenesis.

MeSH Terms
Chromosomes, Human, Pair 3 Chromosomes, Human, Pair 9 DNA-Binding Proteins/genetics,physiology Dementia/genetics,metabolism Female Humans Male Motor Neuron Disease/genetics Ubiquitin/metabolism
Chemicals
DNA-Binding Proteins Ubiquitin
Authors & Affiliations
25 authors, click to expand affiliations / ORCID
Cairns Nigel J
MRCPath, Department of Pathology and Immunology, Washington University School of Medicine, Campus Box 8118, St Louis, MO 63110, USA. [email protected]
Neumann Manuela
Bigio Eileen H
Holm Ida E
Troost Dirk
Hatanpaa Kimmo J
Foong Chan
White Charles L
Schneider Julie A
Kretzschmar Hans A
Carter Deborah
Taylor-Reinwald Lisa
Paulsmeyer Katherine
Strider Jeffrey
Gitcho Michael
Goate Alison M
Morris John C
Mishra Manjari
Kwong Linda K
Stieber Anna
Xu Yan
Forman Mark S
Trojanowski John Q
Lee Virginia M-Y
Mackenzie Ian R A
References (48)
48 references, click to expand
  1. Neuropathological diagnosis and CAG repeat expansion in Huntington's disease.
    J Neurol Neurosurg Psychiatry. 1996 Jan;60(1):78-81 PMID: 8558157
  2. The neuropathology of CAG repeat diseases: review and update of genetic and molecular features.
    Brain Pathol. 1997 Jul;7(3):901-26 PMID: 9217975
  3. Alpha-synuclein in Lewy bodies.
    Nature. 1997 Aug 28;388(6645):839-40 PMID: 9278044
  4. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.
    Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2 PMID: 9330978
  5. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
    Neurosci Lett. 1998 Jul 31;251(3):205-8 PMID: 9726379
  6. Diagnostic criteria for Parkinson disease.
    Arch Neurol. 1999 Jan;56(1):33-9 PMID: 9923759
  7. Consensus statement on the diagnosis of multiple system atrophy.
    J Neurol Sci. 1999 Feb 1;163(1):94-8 PMID: 10223419
  8. Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function.
    J Mol Biol. 2005 May 6;348(3):575-88 PMID: 15826655
  9. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
    Nat Genet. 2005 Aug;37(8):806-8 PMID: 16041373
  10. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.
    Nucleic Acids Res. 2005;33(18):6000-10 PMID: 16254078
  11. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
    Neurology. 2005 Dec 27;65(12):1863-72 PMID: 16237129
  12. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3.
    Brain. 2006 Apr;129(Pt 4):868-76 PMID: 16495328
  13. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia.
    Neurology. 2006 Mar 28;66(6):839-44 PMID: 16421333
  14. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.
    J Neuropathol Exp Neurol. 2006 Jun;65(6):571-81 PMID: 16783167
  15. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.
    Nature. 2006 Aug 24;442(7105):920-4 PMID: 16862115
  16. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.
    Nature. 2006 Aug 24;442(7105):916-9 PMID: 16862116
  17. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
    Ann Neurol. 2006 Sep;60(3):314-22 PMID: 16983685
  18. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.
    Am J Pathol. 2006 Oct;169(4):1343-52 PMID: 17003490
  19. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.
    Hum Mol Genet. 2006 Oct 15;15(20):2988-3001 PMID: 16950801
  20. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Science. 2006 Oct 6;314(5796):130-3 PMID: 17023659
  21. Dementia lacking distinctive histology (DLDH) revisited.
    Acta Neuropathol. 2006 Nov;112(5):551-9 PMID: 16900341
  22. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.
    Brain. 2006 Nov;129(Pt 11):3081-90 PMID: 17071926
  23. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11 PMID: 17084815
  24. Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD.
    BMC Neurol. 2006;6:44 PMID: 17166276
  25. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.
    J Neuropathol Exp Neurol. 2007 Feb;66(2):152-7 PMID: 17279000
  26. Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation.
    Alzheimer Dis Assoc Disord. 2007 Jan-Mar;21(1):1-7 PMID: 17334266
  27. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions.
    J Neuropathol Exp Neurol. 2007 Mar;66(3):177-83 PMID: 17356379
  28. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43.
    Acta Neuropathol. 2007 May;113(5):521-33 PMID: 17219193
  29. Classification and description of frontotemporal dementias.
    Ann N Y Acad Sci. 2000;920:46-51 PMID: 11193176
  30. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.
    EMBO J. 2001 Apr 2;20(7):1774-84 PMID: 11285240
  31. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions.
    Acta Neuropathol. 2001 Jul;102(1):94-102 PMID: 11547957
  32. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.
    Arch Neurol. 2001 Nov;58(11):1803-9 PMID: 11708987
  33. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
    J Neuropathol Exp Neurol. 2002 Jun;61(6):547-56 PMID: 12071638
  34. Higher order arrangement of the eukaryotic nuclear bodies.
    Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13583-8 PMID: 12361981
  35. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.
    J Neuropathol Exp Neurol. 2002 Nov;61(11):935-46 PMID: 12430710
  36. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.
    Neuron. 2003 Oct 9;40(2):427-46 PMID: 14556719
  37. Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions.
    J Struct Biol. 2004 Apr-May;146(1-2):44-57 PMID: 15037236
  38. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.
    Nat Genet. 2004 Apr;36(4):377-81 PMID: 15034582
  39. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance.
    Am J Hum Genet. 2004 Jun;74(6):1322-5 PMID: 15195661
  40. Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia.
    Neurology. 2004 Aug 10;63(3):538-42 PMID: 15304590
  41. Shortfalls in the peptidyl-prolyl cis-trans isomerase protein Pin1 in neurons are associated with frontotemporal dementias.
    Neurobiol Dis. 2004 Nov;17(2):237-49 PMID: 15474361
  42. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration.
    Acta Neuropathol. 2004 Nov;108(5):379-85 PMID: 15351890
  43. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.
    Neurology. 2004 Oct 26;63(8):1376-84 PMID: 15505152
  44. Hereditary diffuse leucoencephalopathy with spheroids.
    Acta Psychiatr Scand Suppl. 1984;314:1-65 PMID: 6595937
  45. Frontal lobe dementia and motor neuron disease.
    J Neurol Neurosurg Psychiatry. 1990 Jan;53(1):23-32 PMID: 2303828
  46. Complete penetration of antibodies into vibratome sections after glutaraldehyde fixation and ethanol treatment: light and electron microscopy for neuropeptides.
    J Histochem Cytochem. 1992 Nov;40(11):1741-9 PMID: 1431060
  47. Overview of dementia lacking distinctive histology: pathological designation of a progressive dementia.
    Dementia. 1993 May-Aug;4(3-4):132-6 PMID: 8401780
  48. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.
    J Neurol Sci. 1994 Jul;124 Suppl:96-107 PMID: 7807156
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
2007-07-00
Pages
227-40
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1941578
Subset
IM
Grants
NIA NIH HHS · P30 AG013854 · United States
NIA NIH HHS · P30 AG010124 · United States
NIA NIH HHS · AG10124 · United States
NIA NIH HHS · P01 AG017586 · United States
NIA NIH HHS · AG12300 · United States
NIA NIH HHS · AG03991 · United States
NIA NIH HHS · U01 AG016976 · United States
NIA NIH HHS · P01 AG003991 · United States
NIA NIH HHS · P50 AG005681 · United States
NIA NIH HHS · P30 AG012300 · United States
NIA NIH HHS · AG05681 · United States
NIA NIH HHS · AG17586 · United States
NIA NIH HHS · AG16976 · United States
NIA NIH HHS · AG13854 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]